Clinical Trial Starts for Biopharma’s Antifungal in Cryptococcal Meningitis

 

Clinical Trial Starts for Biopharma’s Antifungal in Cryptococcal Meningitis

A Research Analyst and/or a member of the Analyst’s household own(s) debt or equity securities of Matinas BioPharma Holdings, Inc. and Amarin Corporation plc stock. Shares of Matinas BioPharma …

More Clinical Trial Starts for Biopharma’s Antifungal in Cryptococcal Meningitis Videos

Leave a Reply